Medifast Inc.

NYSE: MED · Real-Time Price · USD
13.16
0.13 (1.00%)
At close: Aug 15, 2025, 9:57 AM

Medifast Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
2.09M 99.42M 143.57M 164.03M
Depreciation & Amortization
17.4M 13.11M 10.98M 6.81M
Stock-Based Compensation
7.36M 8.19M 11.05M 9.9M
Other Working Capital
13.08M -8.28M -39.54M 39.01M
Other Non-Cash Items
5.03M 5.46M 8.24M 5.16M
Deferred Income Tax
-7.4M 1.21M -924K -3.71M
Change in Working Capital
n/a 20.28M 21.65M -87.65M
Operating Cash Flow
24.48M 147.66M 194.57M 94.55M
Capital Expenditures
-7.45M -6.48M -16.68M -34.21M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-46.59M -54.56M n/a n/a
Sales Maturities Of Investments
27.43M n/a 5.27M 5.14M
Other Investing Acitivies
95K n/a 5.27M 5.14M
Investing Cash Flow
-26.52M -61.05M -11.41M -29.06M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-836K -6.96M -127.96M -62.09M
Dividend Paid
-715K -73.02M -71.62M -63.86M
Other Financial Acitivies
36K 188K n/a 811K
Financial Cash Flow
-1.51M -79.79M -199.58M -125.13M
Net Cash Flow
-3.51M 6.75M -16.49M -59.54M
Free Cash Flow
17.02M 141.17M 177.89M 60.34M